Activation of TRPC6 channels promotes endocannabinoid biosynthesis in neuronal CAD cells.
Calcium influx activates biosynthesis of the endogenous cannabinoids 2-arachidonyl glycerol (2-AG) and anandamide (AEA). The calcium channel involved with endocannabinoid synthesis and release in neurons is still unknown. The canonical TRP (TRPC) channels are calcium-permeable channels that are a homology-based subdivision of the broader class of TRP channels. TRPC3, 6, and 7 are G-protein-gated non-selective cation channels that have been localized to lipid rafts and shown to colocalize with caveolin 1. Because endocannabinoid synthesis has been found to occur "on demand" in a calcium-dependent manner and has been linked to lipid rafts, we explored the potential role of transient receptor potential (TRP) channels in this process. Previously, we observed that after metabolism AEA and arachidonic acid (ArA) can be recycled into new endocannabinoid molecules. Consistent with these previous findings, we found that Cath.a differentiated (CAD) cells pretreated with radiolabeled ArA exhibited a robust increase in 2-AG release in response to TRPC stimulation with the diacylglycerol (DAG) analogue, 1-oleoyl-2-acetyl-sn-glycerol (OAG). Furthermore, cells pretreated with [(3)H]AEA produced a significant amount of AEA and 2-AG upon stimulation of TRPC channels. This process was not mediated through protein kinase C activation. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis revealed that only TRPC6 was present in the CAD cells. siRNA-induced knockdown of TRPC6 in the CAD cells abolished OAG-stimulated production of the endocannabionids. This evidence suggests that TRPC6 may be capable of promoting endocannabinoid synthesis in neuronal cells.
Bardell
Tamera K
TK
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University School of Pharmacy and Pharmaceutical Sciences, West Lafayette, IN 47907-2091, United States.
Barker
Eric L
EL
D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism / Q000494:pharmacology; D001095:Arachidonic Acids / Q000378:metabolism / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D020013:Calcium Signaling / Q000187:drug effects / Q000502:physiology*; D063385:Cannabinoid Receptor Modulators / Q000096:biosynthesis*; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D045744:Cell Line, Tumor; D004075:Diglycerides / Q000494:pharmacology; D015536:Down-Regulation / Q000502:physiology; D063388:Endocannabinoids; D005989:Glycerides / Q000378:metabolism / Q000494:pharmacology; D015640:Ion Channel Gating / Q000187:drug effects / Q000502:physiology; D021962:Membrane Microdomains / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D009474:Neurons / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D053284:Polyunsaturated Alkamides / Q000378:metabolism / Q000494:pharmacology; D034741:RNA, Small Interfering / Q000235:genetics / Q000378:metabolism; D050052:TRPC Cation Channels / Q000819:agonists / Q000235:genetics / Q000378:metabolism*; D000074287:TRPC6 Cation Channel; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
C520323:1-oleoyl-2-acetoyl-sn-glycerol; D001095:Arachidonic Acids; D063385:Cannabinoid Receptor Modulators; D004075:Diglycerides; D063388:Endocannabinoids; D005989:Glycerides; D053284:Polyunsaturated Alkamides; D034741:RNA, Small Interfering; D050052:TRPC Cation Channels; D000074287:TRPC6 Cation Channel; C492146:Trpc6 protein, mouse; D016718:Arachidonic Acid; C094503:glyceryl 2-arachidonate; D014446:Tyrosine 3-Monooxygenase; D002118:Calcium; C078814:anandamide
Br J Cancer. 1976 Jan;33(1):15-26
175819
J Neurosci. 1997 Feb 15;17(4):1217-25
9006967
FEBS Lett. 1998 Jun 12;429(2):152-6
9650580
J Biol Chem. 2005 Dec 2;280(48):39786-94
16204251
J Biol Chem. 2007 Jun 1;282(22):16631-43
17416589
J Neurochem. 2006 Nov;99(4):1164-75
17010161
Nature. 1999 Jan 21;397(6716):259-63
9930701
J Biol Chem. 2004 Oct 1;279(40):41991-7
15292270
J Biol Chem. 2005 Apr 1;280(13):12212-20
15657045
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2625-30
14983059
J Biol Chem. 2008 Apr 4;283(14):9341-9
18227059
Sci STKE. 2001 Jul 10;2001(90):re1
11752662
Neuron. 2010 Feb 11;65(3):320-7
20159446
Mol Hum Reprod. 2002 Oct;8(10):946-51
12356946
J Cell Physiol. 2006 May;207(2):315-21
16331690
J Am Chem Soc. 1971 Jan 13;93(1):217-24
5538858
J Cell Biol. 2003 Nov 10;163(3):463-8
14610053
Curr Neurovasc Res. 2004 Apr;1(2):129-40
16185189
Neuropharmacology. 2008 Dec;55(8):1274-9
18329052
J Biol Chem. 2002 May 24;277(21):19191-7
11897792
Neurochem Res. 1985 Apr;10(4):439-51
2987722
Nature. 1997 Aug 21;388(6644):773-8
9285589
J Biol Chem. 2006 Oct 27;281(43):32540-9
16887806
Pharmacol Biochem Behav. 2005 Jun;81(2):224-38
15935454
J Biol Chem. 2001 Nov 9;276(45):42401-8
11524429
Life Sci. 2005 Aug 19;77(14):1640-50
15978630
Nature. 1993 Sep 2;365(6441):61-5
7689702
J Biol Chem. 2004 Feb 13;279(7):5298-305
14634025
Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):173-92
12052034
Chem Phys Lipids. 2000 Nov;108(1-2):71-87
11106783
Novartis Found Symp. 2004;258:172-85; discussion 185-8, 263-6
15104182
Cell Calcium. 1999 Nov;26(5):201-8
10643558
J Biol Chem. 2002 Nov 8;277(45):43389-98
12177060
Nat Cell Biol. 2007 Jun;9(6):636-45
17486119
Biochem Pharmacol. 1995 Jun 29;50(1):83-90
7605349
Naunyn Schmiedebergs Arch Pharmacol. 2005 Apr;371(4):257-65
15909153
J Biol Chem. 2000 Apr 21;275(16):11934-42
10766822
Science. 1992 Dec 18;258(5090):1946-9
1470919
Biochim Biophys Acta. 2004 Dec 6;1742(1-3):9-20
15590052
J Biol Chem. 2010 Jan 22;285(4):2796-806
19926788
Nat Rev Neurosci. 2003 Nov;4(11):873-84
14595399
J Biol Chem. 1983 Jan 25;258(2):764-9
6822511
J Biol Chem. 2003 Aug 1;278(31):29031-40
12721302
Br J Pharmacol. 2008 Jan;153(2):380-9
17965731
Eur J Biochem. 1996 Aug 15;240(1):53-62
8797835
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6775-80
10359788
Nature. 1994 Dec 15;372(6507):686-91
7990962
J Physiol. 2006 Apr 15;572(Pt 2):359-77
16439426
J Pharm Biomed Anal. 2010 Nov 2;53(3):567-75
20417049
J Neurochem. 1999 May;72(5):2113-9
10217292
FASEB J. 2006 Mar;20(3):503-5
16401641
Pharmacol Rev. 1986 Jun;38(2):151-78
3529128
J Neurochem. 2008 Nov;107(4):987-1000
18778304
Biochem J. 1997 Mar 1;322 ( Pt 2):671-7
9065792
J Neurochem. 2009 Apr;109(2):371-81
19187444
Pflugers Arch. 2005 Oct;451(1):72-80
15971081
J Neurosci. 1993 Mar;13(3):1280-91
7680068
Annu Rev Pharmacol Toxicol. 2009;49:395-426
19281310
Biochem Biophys Res Commun. 1995 Oct 4;215(1):89-97
7575630
Mol Pharmacol. 2004 Apr;65(4):999-1007
15044630
Pharmacol Rev. 1986 Mar;38(1):45-74
2872689
Eur J Pharmacol. 2010 Feb 25;628(1-3):67-74
19958765
Mol Pharmacol. 2009 Jul;76(1):11-7
19389920
Cell. 1992 Feb 21;68(4):673-82
1739974
Eur J Biochem. 1999 Aug;264(1):258-67
10447696
Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6375-80
19307565
Handb Exp Pharmacol. 2007;(179):575-91
17217080
Mol Pharmacol. 2008 Jul;74(1):101-8
18436710
Nature. 1990 Aug 9;346(6284):561-4
2165569